Resolution of Waldenstrom Macroglobulinemia-Associated Autoimmune Hemolysis With Ibrutinib [Case Report]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Tripathi, A., Steingart, R. Tags: Chemotherapy, Biologic Therapy Case Report Source Type: research
Selection of Optimal Adjuvant Chemotherapy Regimens for Early Breast Cancer and Adjuvant Targeted Therapy for HER2-Positive Breast Cancers: An American Society of Clinical Oncology Guideline Adaptation of the Cancer Care Ontario Clinical Practice Guideline Summary [Guideline Summaries]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Denduluri, N., Somerfield, M. R., Wolff, A. C. Tags: Clinical guidelines, Management and treatment, Chemotherapy, Hormonal Therapy, ASCO Guidelines, Non-ASCO Guidelines Guideline Summaries Source Type: research
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: American Society of Clinical Oncology Endorsement of Cancer Care Ontario Guideline Recommendations Summary [Guideline Summaries]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Henry, N. L., Somerfield, M. R., Krop, I. E. Tags: Clinical guidelines, Management and treatment, Quality of care, Epidemiology, Surgery, Chemotherapy, Hormonal Therapy, ASCO Guidelines, Non-ASCO Guidelines Guideline Summaries Source Type: research
Young Men With Cancer Experience Low Referral Rates for Fertility Counseling and Sperm Banking [CARE DELIVERY]
Conclusion:
There is a low rate of fertility counseling and referral for sperm banking in young men with cancer receiving chemotherapy. Further work is needed to develop interventions to improve fertility counseling rates and opportunities for sperm banking. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Grover, N. S., Deal, A. M., Wood, W. A., Mersereau, J. E. Tags: Communication, Young adult, Adult, Complications of cancer and cancer treatment, Survivorship, Treatment related issues, Quality of care, Management and treatment, Quality of Care CARE DELIVERY Source Type: research
Treatment of Relapsed Germ Cell Tumors: Time For Something New? [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Campbell, M. T., Jonasch, E. Tags: Clinical guidelines, Systemic Therapy, Combined Modality Therapy COMMENTARIES Source Type: research
Recurrent Germ Cell Tumors: Lets Try to Cure Them All [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Bosl, G. J. Tags: Combined Modality Therapy COMMENTARIES Source Type: research
Salvage Therapy for Patients With Germ Cell Tumor [Clinical Reviews]
The introduction of cisplatin combination chemotherapy, 40 years ago, transformed metastatic testicular germ cell tumors from an almost uniformly fatal disease into a model for a curable neoplasm. Before the era of platinum combination chemotherapy, the 5-year survival rate among men with metastatic testicular germ cell tumors was 5% to 10%. Currently, the 5-year survival rate is 80% for patients with metastatic disease and 95% overall. Despite the substantial advances in the treatment of germ cell tumors, 20% to 30% of patients will relapse after first-line chemotherapy and will require additional salvage therapies. Stand...
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Rashdan, S., Einhorn, L. H. Tags: Surgery, Systemic Therapy, Combined Modality Therapy, Diagnosis & Staging Clinical Reviews Source Type: research
Hypercalcemia of Malignancy: A New Twist on an Old Problem [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Mohammad, K. S., Guise, T. A. Tags: Complications of cancer and cancer treatment, Supportive Care COMMENTARIES Source Type: research
Calcium and Cancer: Of Evil Humors and Innocent Bystanders [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Harvey, R. D. Tags: Complications of cancer and cancer treatment, Supportive Care COMMENTARIES Source Type: research
Cancer-Related Hypercalcemia [Clinical Reviews]
Hypercalcemia has been reported to occur in up to 30% of patients who have a malignancy. Hypercalcemia is most common in those who have later-stage malignancies and predicts a poor prognosis for those with it. The most common causes include humoral hypercalcemia of malignancy mediated by parathyroid hormone–related peptide, osteolytic cytokine production, and excess 1,25-dihydroxy vitamin D production. However, the etiology is not always mediated by malignancy. Hypercalcemia can occur in those with malignancy and an additional etiology for hypercalcemia such as primary hyperparathyroidism or granulomatous diseases. T...
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Goldner, W. Tags: Management and treatment Clinical Reviews Source Type: research
Personalized Therapeutics and Value in Renal Cell Carcinoma: Moving Beyond Lines of Therapy [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Posadas, E. M., Figlin, R. A. Tags: Systemic Therapy COMMENTARIES Source Type: research
Changing Landscape of Refractory Renal Cell Carcinoma [COMMENTARIES]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Rini, B. I. Tags: Systemic Therapy, Combined Modality Therapy COMMENTARIES Source Type: research
Therapeutic Strategies for Patients With Metastatic Renal Cell Carcinoma in Whom First-Line Vascular Endothelial Growth Factor Receptor-Directed Therapies Fail [Clinical Reviews]
This article comprises both a systematic review of the literature and recommendations for second-line therapeutic strategies for patients with metastatic clear cell renal cell carcinoma in whom inhibitors of vascular endothelial growth factor have failed. (Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Malouf, G. G., Flippot, R., Khayat, D. Tags: Clinical guidelines, Management and treatment, Clinical guidelines, Clinical guidelines, Systemic Therapy, Combined Modality Therapy Clinical Reviews Source Type: research
Managing the Clues in Cancer Care [Editorials]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Berry, L. L., Jacobson, J. O., Stuart, B. Tags: Editorials Source Type: research
New Diagnosis Bundle: Improving Care Delivery for Patients With Newly Diagnosed Cancer [Editorials]
(Source: Journal of Oncology Practice)
Source: Journal of Oncology Practice - May 10, 2016 Category: Cancer & Oncology Authors: Jacobson, J. O., Rotenstein, L. S., Berry, L. L. Tags: Communication, Doctor-patient communication, Communication, Quality, Quality of care, Caregiver, Family member, General public Editorials Source Type: research
